Results 121 to 130 of about 411,697 (349)
Objective The presence of antinuclear antibodies (ANAs) is characteristic for systemic lupus erythematosus (SLE). Antibody dynamics over time are thought to reflect the cellular source of ANAs and their therapeutic targetability. Anti–double‐stranded DNA (anti‐dsDNA) is the most prevalent and well‐studied of all ANAs, and fluctuations in anti‐dsDNA ...
Hugo J. van Dooren +16 more
wiley +1 more source
Tumid lupus erythematosus is an uncommon subtype of chronic cutaneous lupus erythematosus. Hereby, we report a 36-year-old male patient with tumid lupus erythematosus who presented with erythematous papules and plaques on the face and neck who showed ...
Funda Tamer +3 more
doaj +1 more source
Recurrent podocytopathy in a patient with systemic lupus erythematosus
Podocytopathy in systemic lupus erythematosus is characterised by diffuse foot process effacement without significant peripheral capillary wall immune deposits as seen on electron microscopy.
Shereen Paramalingam +3 more
doaj +1 more source
STUDIES ON THE MECHANISM OF THE LUPUS ERYTHEMATOSUS (L.E.) PHENOMENON* [PDF]
Alan C. Aisenberg
openalex +1 more source
Objective Autoimmune diseases, such as systemic lupus erythematosus (SLE), are associated with pulmonary arterial hypertension (PAH), a condition that can lead to heart failure. However, whether T cells also contribute to the occurrence of PAH in SLE has not been clarified.
Shuliang Jing +9 more
wiley +1 more source
LP-048 Characteristics and clinical outcome of incomplete systemic lupus erythematosus
Anastasiia Shumilova +6 more
doaj +1 more source
Pulmonary Changes in Disseminated Lupus Erythematosus [PDF]
J. D. Aitchison, A. W. Williams
openalex +1 more source
Mucosal‐Associated Invariant T Cells in Rheumatic Diseases
Mucosal‐associated invariant T (MAIT) cells are innate‐like T cells defined by their semi‐invariant T cell receptor and restriction by the major histocompatibility complex class I–related molecule (MR1). These cells are primarily activated by microbial‐derived metabolites presented by MR1 or by cytokines.
Manon Lesturgie‐Talarek +7 more
wiley +1 more source

